2023上半年营收增长0.7%,营业利润萎缩17.7%,净利润大幅萎缩72.2%。
目前市盈率17.6,市盈率TTM提高...查看全文
药明康德2019-12-04 12:17
▎医药观澜/报道
12月2日,知名网站GEN发布《2019全球免疫肿瘤学初创公司TOP10》,其中包括未上市的癌症免疫疗法企业,该排名按照企业总募资金额进行排名。值得一提的是,天境生物则以3.798亿美元募资额,成为唯一一家上榜的中国免疫肿瘤学初创公司。我们一起来看看,在即将过去的这一年,这1...查看全文
$SITE Centers(SITC)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001564590-21-027543 Act: 34 Size: 231 KB 网页链接
$SITE Centers(SITC)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-21-032311 Size: 6 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-032015 Size: 5 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-031213 Size: 7 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-030904 Size: 5 KB 网页链接
$SITE Centers(SITC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-21-021955 Act: 34 Size: 8 MB 网页链接
$SITE Centers(SITC)$ 内部交易: 2021-04-26,Director,Otto Alexander ,卖出,8500000普通股, $14.44
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-017185 Size: 4 KB 网页链接
$SITE Centers(SITC)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-137083 Act: 34 Size: 50 KB 网页链接
$SITE Centers(SITC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-21-019941 Act: 34 Size: 5 MB 网页链接